Researchers have created a new technique to detect glycoproteins in biological fluids. The Purdue University team engineered an array they called polyGPA (polymer-based reverse phase glycoprotein array) and have shown proof-of-concept...Show More Summary
(International Association for the Study of Lung Cancer) Efforts to control tobacco as a public health threat have escalated as clinicians and public health advocates have coalesced to beat back threats from tobacco companies through public advocacy, public health, and pension reform. Show More Summary
Death has been relentless this year, with one quite important exception – me. When I was diagnosed with cancer 10 years ago, the worst case scenario was ‘dead by Christmas 2006’ What a great year 2016 was. It was a tremendous year, full of hope. Show More Summary
Richard Gorlick, M.D., an internationally recognized expert in pediatric oncology and hematology, today joined The University of Texas MD Anderson Children's Cancer Hospital as the division head and department chair of Pediatrics.
(Columbia University Medical Center) In a Phase I study, 8 out of 12 patients with relapsed and/or chemotherapy refractory blood cancers responded to a combination of the chemotherapy drugs thioguanine and decitabine; some of the responders had relapsed after treatment with decitabine alone.
(Dana-Farber Cancer Institute) A combination of two targeted agents -- one approved by the Food and Drug Administration and one undergoing testing -- has demonstrated safety as well as encouraging signs of effectiveness in a phase 1 clinical trial in patients with relapsed or hard-to-treat chronic lymphocytic leukemia or mantle cell lymphoma.
Gertrudis Torres said her son and daughter have given her motivation to beat the disease, even as her substantial grief and her weakened physical strength made the challenge seem impossible at times.
New study finds that smoking even just a few times a week raises the risk of dying of lung cancer and other causes
North Chicago, Ill. and Baltimore, Md. December 5, 2016 - AbbVie (NYSE: ABBV), a global biopharmaceutical company, and the Johns Hopkins University School of Medicine today announced that they signed a five-year collaboration agreement with the goal of advancing medical oncology research and discovery at both organizations.
Skin cancer is the most common form of cancer in the U.S., and the deadliest form of skin cancer is melanoma. The Melanoma Research Laboratory at Mayo Clinic is working to improve survival rates by developing novel treatments for metastatic melanoma. On the next Mayo Clinic Radio program, Dr. Svetomir Markovic, director of the lab, will […]
The University of Arkansas for Medical Sciences (UAMS) is collaborating with Dana-Farber Cancer Institute and Celgene Corp. to compile the largest set of high-quality
In a Phase I study, 8 out of 12 patients with relapsed and/or chemotherapy refractory blood cancers responded to a combination of the chemotherapy drugs thioguanine and decitabine; some of the responders had relapsed after treatment with decitabine alone.
Just 1 oz a day reduces risk of cancer and heart disease. Analysis suggests even a small daily serving cuts the risk of coronary heart disease by 30 per cent, cancer by 15 per cent and premature death by 22 per cent. It can also halve the risk of respiratory disease and reduces diabetes by [...]
(University of Basel) A research team at the University of Basel's Biozentrum has investigated the expression of ribosomal proteins in a wide range of human tissues including tumors and discovered a cancer type specific signature. As the researchers report in Genome Biology this 'cancer signature' could potentially be used to predict the progression of the disease.
(International Association for the Study of Lung Cancer) Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer. Their remarks come on the first day of the IASLC 17th World Conference on Lung Cancer in Vienna, Austria.
(H. Lee Moffitt Cancer Center & Research Institute) Acute myeloid leukemia, or AML, is a type of cancer of the blood and bone marrow. It occurs most often in older populations and progresses rapidly, interfering with the production of red blood cells, white blood cells and platelets. Treatments include chemotherapy, drug therapy and stem-cell transplants.
(H. Lee Moffitt Cancer Center & Research Institute) Patients with myelodysplastic syndromes (MDS) suffer from a reduction in the number of different types of blood cells, including red blood cells leading to the development of anemia. Show More Summary
When it comes to the current state of cancer survival, Susan Bates feels like many of the rest of us. “It’s incredibly frustrating,” she says. For Bates, who treats pancreatic and other cancers at Columbia University Medical Center,Show More Summary
This month, I thought I would be writing about presenting an agenda to President-elect Clinton's transition team, with our suggestions for a plan to end breast cancer. As a staunch supporter of the National Breast Cancer Coalition'sShow More Summary
A research team has investigated the expression of ribosomal proteins in a wide range of human tissues including tumors and discovered a cancer type specific signature. This “cancer signature” could potentially be used to predict the progression of the disease.